Literature DB >> 14500885

Amino acid sequence and crystal structure of BaP1, a metalloproteinase from Bothrops asper snake venom that exerts multiple tissue-damaging activities.

Leandra Watanabe1, John D Shannon, Richard H Valente, Alexandra Rucavado, Alberto Alape-Girón, Aura S Kamiguti, R David G Theakston, Jay W Fox, José María Gutiérrez, Raghuvir K Arni.   

Abstract

BaP1 is a 22.7-kD P-I-type zinc-dependent metalloproteinase isolated from the venom of the snake Bothrops asper, a medically relevant species in Central America. This enzyme exerts multiple tissue-damaging activities, including hemorrhage, myonecrosis, dermonecrosis, blistering, and edema. BaP1 is a single chain of 202 amino acids that shows highest sequence identity with metalloproteinases isolated from the venoms of snakes of the subfamily Crotalinae. It has six Cys residues involved in three disulfide bridges (Cys 117-Cys 197, Cys 159-Cys 181, Cys 157-Cys 164). It has the consensus sequence H(142)E(143)XXH(146)XXGXXH(152), as well as the sequence C(164)I(165)M(166), which characterize the "metzincin" superfamily of metalloproteinases. The active-site cleft separates a major subdomain (residues 1-152), comprising four alpha-helices and a five-stranded beta-sheet, from the minor subdomain, which is formed by a single alpha-helix and several loops. The catalytic zinc ion is coordinated by the N(epsilon 2) nitrogen atoms of His 142, His 146, and His 152, in addition to a solvent water molecule, which in turn is bound to Glu 143. Several conserved residues contribute to the formation of the hydrophobic pocket, and Met 166 serves as a hydrophobic base for the active-site groups. Sequence and structural comparisons of hemorrhagic and nonhemorrhagic P-I metalloproteinases from snake venoms revealed differences in several regions. In particular, the loop comprising residues 153 to 176 has marked structural differences between metalloproteinases with very different hemorrhagic activities. Because this region lies in close proximity to the active-site microenvironment, it may influence the interaction of these enzymes with physiologically relevant substrates in the extracellular matrix.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14500885      PMCID: PMC2366908          DOI: 10.1110/ps.03102403

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  44 in total

1.  Purification, cloning and sequence analyses for pro-metalloprotease-disintegrin variants from Deinagkistrodon acutus venom and subclassification of the small venom metalloproteases.

Authors:  I H Tsai; Y M Wang; T Y Chiang; Y L Chen; R J Huang
Journal:  Eur J Biochem       Date:  2000-03

2.  Using CLUSTAL for multiple sequence alignments.

Authors:  D G Higgins; J D Thompson; T J Gibson
Journal:  Methods Enzymol       Date:  1996       Impact factor: 1.600

3.  Crystal structure of H2-proteinase from the venom of Trimeresurus flavoviridis.

Authors:  T Kumasaka; M Yamamoto; H Moriyama; N Tanaka; M Sato; Y Katsube; Y Yamakawa; T Omori-Satoh; S Iwanaga; T Ueki
Journal:  J Biochem       Date:  1996-01       Impact factor: 3.387

4.  Improved tools for biological sequence comparison.

Authors:  W R Pearson; D J Lipman
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

5.  Jararhagin ECD-containing disintegrin domain: expression in escherichia coli and inhibition of the platelet-collagen interaction.

Authors:  A M Moura-da-Silva; A Línica; M S Della-Casa; A S Kamiguti; P L Ho; J M Crampton; R D Theakston
Journal:  Arch Biochem Biophys       Date:  1999-09-15       Impact factor: 4.013

Review 6.  Hemorrhagic metalloproteinases from snake venoms.

Authors:  J B Bjarnason; J W Fox
Journal:  Pharmacol Ther       Date:  1994       Impact factor: 12.310

7.  Identification of the cleavage sites by a hemorrhagic metalloproteinase in type IV collagen.

Authors:  E N Baramova; J D Shannon; J B Bjarnason; J W Fox
Journal:  Matrix       Date:  1990-05

8.  Isolation and characterization of a metalloproteinase with weak hemorrhagic activity from the venom of the snake Bothrops asper (terciopelo).

Authors:  J M Gutiérrez; M Romero; C Díaz; G Borkow; M Ovadia
Journal:  Toxicon       Date:  1995-01       Impact factor: 3.033

9.  Batimastat, a potent matrix mealloproteinase inhibitor, exhibits an unexpected mode of binding.

Authors:  I Botos; L Scapozza; D Zhang; L A Liotta; E F Meyer
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-02       Impact factor: 11.205

10.  Refined 2.0 A X-ray crystal structure of the snake venom zinc-endopeptidase adamalysin II. Primary and tertiary structure determination, refinement, molecular structure and comparison with astacin, collagenase and thermolysin.

Authors:  F X Gomis-Rüth; L F Kress; J Kellermann; I Mayr; X Lee; R Huber; W Bode
Journal:  J Mol Biol       Date:  1994-06-17       Impact factor: 5.469

View more
  26 in total

1.  Purification and characterization of a new weak hemorrhagic metalloproteinase BmHF-1 from Bothrops marajoensis snake venom.

Authors:  Frank Denis Torres-Huaco; Luis Alberto Ponce-Soto; Daniel Martins-de-Souza; Sergio Marangoni
Journal:  Protein J       Date:  2010-08       Impact factor: 2.371

2.  Unraveling the distinctive features of hemorrhagic and non-hemorrhagic snake venom metalloproteinases using molecular simulations.

Authors:  Raoni Almeida de Souza; Natalia Díaz; Ronaldo Alves Pinto Nagem; Rafaela Salgado Ferreira; Dimas Suárez
Journal:  J Comput Aided Mol Des       Date:  2015-12-16       Impact factor: 3.686

3.  Crystallization and preliminary X-ray studies of a non-haemorrhagic fibrin(ogen)olytic metalloproteinase from the venom of Agkistrodon acutus.

Authors:  Jing Hou; Ming Li; Jiashu Chen; Pengxin Qiu; Xiuxia Liang; Zhiyong Lou; Zihe Rao; Guangmei Yan
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2005-03-12

4.  cDNA cloning, expression and fibrin(ogen)olytic activity of two low-molecular weight snake venom metalloproteinases.

Authors:  Ying Jia; Sara Lucena; Esteban Cantu; Elda E Sánchez; John C Pérez
Journal:  Toxicon       Date:  2009-04-16       Impact factor: 3.033

5.  Complete amino-acid sequence, crystallization and preliminary X-ray diffraction studies of leucurolysin-a, a nonhaemorrhagic metalloproteinase from Bothrops leucurus snake venom.

Authors:  Rodrigo Novaes Ferreira; Breno Rates; Michael Richardson; Beatriz Gomes Guimarães; Eládio Oswaldo Flores Sanchez; Adriano Monteiro de Castro Pimenta; Ronaldo Alves Pinto Nagem
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2009-07-25

6.  Identification of new snake venom metalloproteinase inhibitors using compound screening and rational Peptide design.

Authors:  Fabián Villalta-Romero; Anna Gortat; Andrés E Herrera; Rebeca Arguedas; Javier Quesada; Robson Lopes de Melo; Juan J Calvete; Mavis Montero; Renato Murillo; Alexandra Rucavado; José María Gutiérrez; Enrique Pérez-Payá
Journal:  ACS Med Chem Lett       Date:  2012-06-14       Impact factor: 4.345

7.  Molecular models of the Mojave rattlesnake (Crotalus scutulatus scutulatus) venom metalloproteinases reveal a structural basis for differences in hemorrhagic activities.

Authors:  Ruben K Dagda; Sardar E Gasanov; Boris Zhang; William Welch; Eppie D Rael
Journal:  J Biol Phys       Date:  2014-02-13       Impact factor: 1.365

8.  The snake venom metalloproteinase BaP1 induces joint hypernociception through TNF-alpha and PGE2-dependent mechanisms.

Authors:  C M Fernandes; C de Fátima Pereira Teixeira; A C R M Leite; J M Gutiérrez; F A C Rocha
Journal:  Br J Pharmacol       Date:  2007-06-25       Impact factor: 8.739

9.  Determination of the structure form of the fourth ligand of zinc in Acutolysin A using combined quantum mechanical and molecular mechanical simulation.

Authors:  Emilia L Wu; Kin-Yiu Wong; Xin Zhang; Keli Han; Jiali Gao
Journal:  J Phys Chem B       Date:  2009-02-26       Impact factor: 2.991

10.  Modulation of Diverse Procoagulant Venom Activities by Combinations of Platinoid Compounds.

Authors:  Vance G Nielsen
Journal:  Int J Mol Sci       Date:  2021-04-28       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.